Asia Pacific orthopedic surgical robots market will grow by 29.6% annually with a total addressable market cap of $23.75 billion over 2023-2032, driven by the increasing incidence of musculoskeletal diseases associated with the growing elderly population, an increasing demand for clinical digitalization, the rising funds allocated for medical robots research and technological advancements in orthopedic surgical robots, improved hospital outcomes, and the decreasing price of robot-assisted orthopedics surgery. Asia Pacific orthopedic surgical robot and computer-assisted surgery market is poised to achieve significant growth because the devices provide high accuracy, consistent, superior outcomes for clinicians far beyond what has previously been available.
Highlighted with 34 tables and 50 figures, this 127-page report “Asia Pacific Orthopedic Surgical Robots Market 2022-2032 by Offering (Robotic Systems, Accessories and Consumables, Software and Services), Surgery Type (Knee, Hip, Others), End User (Hospitals, Clinics, ASCs), Distribution Channel (Direct Sales, Distributors), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific orthopedic surgical robots market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific orthopedic surgical robots market in every aspect of the classification from perspectives of Offering, Surgery Type, End User, Distribution Channel, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Robotic Systems
o Robot Machines
o Navigation Systems
o Planners and Simulators
o Other Components
• Accessories and Consumables
o Disposables
o CNC Machines
o Robotic Tools
o Other Instruments and Accessories
• Software and Services

Based on Surgery Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Knee Surgery
• Hip Surgery
• Other Surgeries

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers (ASCs)
• Other End Users

By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Direct Sales
• Third-party Distributors

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Offering, Surgery Type, and End User over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accuray Incorporated
Auris Health Inc.
Brainlab AG
Curexo Technology Corp.
DePuy Synthes (Johnson & Johnson)
Globus Medical
Intuitive Surgical
Kinamed Inc.
Mazor Robotics Ltd.
Medrobotics Corporation
Medtronic Inc.
Merge Healthcare
Nordson Corporation
NuVasive Inc.
OMNIlife Science, Inc.
Shenzhen Institutes of Advanced Technology (SIAT)
Simbionix USA Corp.
Smith & Nephew PLC
Stryker Corp. / MAKO
Think Surgical, Inc.
Wright Medical Technology, Inc.
Zimmer Biomet Holdings, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)